ArticleInvestigational new drugs2022

A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients.

Thomas Yau et al.PubMed ↗Publisher ↗

No numbers read from the abstract.